• For Researchers

New funding to unite transatlantic forces for the early detection of cancer

We're launching new research funding grants to encourage new collaborations between researchers in the UK and US in the priority field of cancer early detection We're launching new research funding grants to encourage new collaborations between researchers in the UK and US in the priority field of cancer early detection

15 September 2017

• For Researchers

BT1718: developing a first-in-class therapy in an award-winning partnership

Our Centre for Drug Development, working in partnerships with Bicycle Therapeutics, is trialing a first-in-class drug in patients with advanced solid tumours. Our Centre for Drug Development, working in partnerships with Bicycle Therapeutics, is trialing a first-in-class drug in patients with advanced solid tumours.

15 August 2017

• For Researchers

Accelerated UK work visa route for early- and mid-career researchers

We're making it easier for exceptionally talented scientists and promising new researchers from outside the UK to join our research community. We're making it easier for exceptionally talented scientists and promising new researchers from outside the UK to join our research community.

31 July 2017

• For Researchers

Temozolomide: the brain tumour superstar

In this article Professor Malcolm Stevens reflects on the work that led to his team’s discovery of temozolomide. In this article Professor Malcolm Stevens reflects on the work that led to his team’s discovery of temozolomide.

26 July 2017

• For Researchers

Rucaparib: targeting DNA repair and a patient's perspective

Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib. Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib.

21 July 2017

• For Researchers

Using patient data in research to improve cancer treatments and increase patient survival

Patient data are vital for researchers seeking to improve cancer diagnosis, treatments, and care. Patient data are vital for researchers seeking to improve cancer diagnosis, treatments, and care.

5 July 2017

• For Researchers

Funding more clinical academics than ever before

We are continuing to build on our commitment to provide the right support for clinical academics working in cancer research. We are continuing to build on our commitment to provide the right support for clinical academics working in cancer research.

3 July 2017

• For Researchers

Dave Sims: A family uniting against cancer

Mark Sims was 15 when he was first diagnosed with melanoma in 2003. Here, his brother Dave shares Mark's story of how he got involved in the PEACE study. Mark Sims was 15 when he was first diagnosed with melanoma in 2003. Here, his brother Dave shares Mark's story of how he got involved in the PEACE study.

20 June 2017

• For Researchers

Improving radiotherapy for brain cancers

A Q&A with Dr Ross Carruthers on DNA damage response mechanisms in glioblastoma, and why these cancers are particularly resistant to radiotherapy. A Q&A with Dr Ross Carruthers on DNA damage response mechanisms in glioblastoma, and why these cancers are particularly resistant to radiotherapy.

20 June 2017

• For Researchers

Hacking into normality: Gerard Evan

An interview with Gerard Evan on a new way of viewing pancreatic and lung cancer and the implications for understanding the disease, and how to treat it. An interview with Gerard Evan on a new way of viewing pancreatic and lung cancer and the implications for understanding the disease, and how to treat it.

20 June 2017

• For Researchers

Tackling hard-to-treat cancers from every angle

Improving the quality and quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of our research activity. Improving the quality and quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of our research activity.

20 June 2017

• For Researchers

Behind the scenes: pioneering human stem cell research

In 2016 Dr Kathy Niakan became the first person in the world to gain regulatory approval to edit the genomes of human embryos for research. In 2016 Dr Kathy Niakan became the first person in the world to gain regulatory approval to edit the genomes of human embryos for research.

20 June 2017